Cargando…

New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer

With recent advances in molecular pathology and the development of new chemotherapy regimens, the knowledge of the molecular alterations of pancreatic ductal adenocarcinoma (PDAC) is becoming appealing for stratifying patients for prognosis and response to a defined treatment. Archival formalin-fixe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Archibugi, Livia, Testoni, Sabrina Gloria Giulia, Redegalli, Miriam, Petrone, Maria Chiara, Reni, Michele, Falconi, Massimo, Doglioni, Claudio, Capurso, Gabriele, Arcidiacono, Paolo Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883177/ https://www.ncbi.nlm.nih.gov/pubmed/31798775 http://dx.doi.org/10.4251/wjgo.v11.i11.933

Ejemplares similares

RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features
por: Archibugi, Livia, et al.
Publicado: (2020)

Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2020)

Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management
por: Archibugi, Livia, et al.
Publicado: (2022)

Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2021)

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy
por: Rossi, Gemma, et al.
Publicado: (2022)

Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
por: Rossi, Gemma, et al.
Publicado: (2022)

Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2023)

Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials
por: Capurso, Gabriele, et al.
Publicado: (2020)

High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures
por: Archibugi, Livia, et al.
Publicado: (2021)

Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma
por: Vanella, Giuseppe, et al.
Publicado: (2022)

Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study
por: Tacelli, Matteo, et al.
Publicado: (2022)

Needle-knife fistulotomy vs. standard biliary sphincterotomy for choledocholithiasis: common bile duct stone recurrence and complication rate
por: Archibugi, Livia, et al.
Publicado: (2019)

Giardia lamblia Infection in a Duodenal Duplication Cyst as a Potential Cause of Recurrent Acute Pancreatitis
por: Ponz de Leon Pisani, Ruggero, et al.
Publicado: (2023)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol
por: Consolandi, Monica, et al.
Publicado: (2020)

EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case–control study
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2022)

Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach
por: Archibugi, Livia, et al.
Publicado: (2023)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2020)

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020)

EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients?
por: Vanella, Giuseppe, et al.
Publicado: (2021)

Correction: Long-term follow-up of low-risk branchduct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?
por: Petrone, Maria Chiara, et al.
Publicado: (2018)

Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?
por: Petrone, Maria Chiara, et al.
Publicado: (2018)

The resectable pancreatic ductal adenocarcinoma: To FNA or not to FNA? A diagnostic dilemma, FNA pros
por: Petrone, Maria Chiara, et al.
Publicado: (2017)

Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment
por: Piciucchi, Matteo, et al.
Publicado: (2015)

Pancreatic cystic neoplasms in 2018: The final cut
por: Capurso, Gabriele, et al.
Publicado: (2018)

The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients
por: Piciucchi, Matteo, et al.
Publicado: (2017)

Comparison of capillary versus aspiration technique in endoscopic ultrasound-guided fine-needle aspiration: A preliminary report
por: Dabizzi, E., et al.
Publicado: (2014)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2016)

Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study
por: Archibugi, Livia, et al.
Publicado: (2017)

Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta‐analysis with pre and post‐test probability assessment
por: Capurso, Gabriele, et al.
Publicado: (2023)

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
por: Capurso, Gabriele, et al.
Publicado: (2019)

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019)

Risk factors for the occurrence of ampullary tumors: A case‐control study
por: Zaccari, Piera, et al.
Publicado: (2022)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
por: Gentiluomo, Manuel, et al.
Publicado: (2023)

EUS-guided gastroenterostomy in a COVID-19-infected patient with duodenal stenosing lymphoma (with videos)
por: Rossi, Gemma, et al.
Publicado: (2021)

Drug resistance in pancreatic cancer: New player caught in act
por: Capurso, Gabriele, et al.
Publicado: (2019)

Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
por: Gasparini, Giulia, et al.
Publicado: (2019)

Patient Reported Experience Measure in Endoscopic Ultrasonography: The PREUS Study Protocol
por: Apadula, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hah19tku421ermsc0qag1j3le7